about
Pathogenesis of lethal cardiac arrhythmias in Mecp2 mutant mice: implication for therapy in Rett syndromeRett Syndrome: Crossing the Threshold to Clinical TranslationManagement of epilepsy in patients with Rett syndrome: perspectives and considerationsTargeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromesRett Syndrome: Reaching for Clinical TrialsClinical Guidelines for Management of Bone Health in Rett Syndrome Based on Expert Consensus and Available EvidenceMeCP2 deficiency results in robust Rett-like behavioural and motor deficits in male and female ratsNetwork hyperexcitability in hippocampal slices from Mecp2 mutant mice revealed by voltage-sensitive dye imaging.Preclinical research in Rett syndrome: setting the foundation for translational success.Clinical review of genetic epileptic encephalopathiesTwenty-four hour quantitative-EEG and in-vivo glutamate biosensor detects activity and circadian rhythm dependent biomarkers of pathogenesis in Mecp2 null mice.β2-Adrenergic receptor agonist ameliorates phenotypes and corrects microRNA-mediated IGF1 deficits in a mouse model of Rett syndromeWhat you seize is what you get: do we yet understand epilepsy in rett syndrome?Pubertal development in Rett syndrome deviates from typical femalesExperimental models of Rett syndrome based on Mecp2 dysfunction.Why do seizures occur when they do? Situations perceived to be associated with increased or decreased seizure likelihood in people with epilepsy and intellectual disability.MeCP2 is critical within HoxB1-derived tissues of mice for normal lifespanTreatment of cardiac arrhythmias in a mouse model of Rett syndrome with Na+-channel-blocking antiepileptic drugs.Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndromeAutism spectrum disorder and epilepsy: Disorders with a shared biology.Genetic and epileptic features in Rett syndromeEpileptogenesis: can the science of epigenetics give us answers?Clinical characteristics of children with rett syndrome.The phenotype associated with a large deletion on MECP2.The Changing Face of Survival in Rett Syndrome and MECP2-Related Disorders.Improving Treatment Trial Outcomes for Rett Syndrome: The Development of Rett-specific Anchors for the Clinical Global Impression ScaleLongitudinal course of epilepsy in Rett syndrome and related disorders.Growth failure and outcome in Rett syndrome: specific growth references.Activity-dependent BDNF release and TRPC signaling is impaired in hippocampal neurons of Mecp2 mutant miceThe relationship of Rett syndrome and MECP2 disorders to autism.Rett syndrome: exploring the autism link.Comparative DNA methylation among females with neurodevelopmental disorders and seizures identifies TAC1 as a MeCP2 target gene.Caretaker Quality of Life in Rett Syndrome: Disorder Features and Psychological Predictors.NMDA receptor regulation prevents regression of visual cortical function in the absence of Mecp2.Evaluation of current pharmacological treatment options in the management of Rett syndrome: from the present to future therapeutic alternatives.Progress in Rett Syndrome: from discovery to clinical trialsRecent Progress in Rett Syndrome and MeCP2 Dysfunction: Assessment of Potential Treatment OptionsComorbidity clusters in autism spectrum disorders: an electronic health record time-series analysisJointly reduced inhibition and excitation underlies circuit-wide changes in cortical processing in Rett syndrome.Neurobiologically-based treatments in Rett syndrome: opportunities and challenges.
P2860
Q24632189-F1588E84-2011-47A2-84E8-0E92564B0946Q26772909-535E91CB-10FE-46FA-A7E0-64FAAD3F4838Q26824789-6D3F565A-07CE-4800-A8CD-A2CC2AC7D55FQ27023257-94174244-B4D0-4E47-A51D-EE9D49F2E2C3Q27337778-4CCBF30A-3570-4DDB-8132-85E0B8E31105Q28553154-C43659C6-BCA3-4D91-B68A-DED32954D21DQ28818736-4B0CC5F4-6B8B-45BA-9FE0-F2AB44F20F37Q30499472-C85F2930-B906-4F35-B92A-90AAC1DD0B73Q30527828-4F0FBB2A-BDF1-4186-A5A6-0632762132FCQ30537230-730B4239-E442-4A78-B8BC-AA6978E64800Q30581752-6201AC23-9AA4-4CD5-A139-4ED6027FBDF1Q33919634-A6292AF4-6197-481B-9815-0C1EAF4D9B8CQ34306205-76F81B2E-32FE-4F61-BD5F-9B7427B3028CQ34623283-F02F7C09-1E51-4858-A083-60A1FA53E6A1Q34686591-0078BB9B-8376-4050-AB13-CA1498905644Q34759795-0FEB3A79-9C80-4664-9506-4234558C9E78Q35219982-32C78CFF-A11B-4E11-85A6-3418F8A3E716Q35237722-EC260C73-707A-4BB7-BAD2-686E9429D5D4Q35492500-216ABFA3-D300-400B-BDB0-E0BDDCC6BD51Q35762766-99649BA3-B9D9-4B82-83DE-DBC656B72CEEQ35932132-D0E03C4A-DFCA-40C0-A845-954C76EA81C0Q36008878-2AECF525-9783-405D-A5DE-205DD867752BQ36105595-F044A94F-0EE9-456B-B0EC-377321570AA0Q36170434-39A616A3-47C4-438B-99DF-847A016F5AEEQ36173598-D467C814-2E32-44E4-A29D-61A5B9FAE5BEQ36176918-ECC3EDA9-120F-48EF-BA51-CF200D0F697FQ36232006-7D768B57-0D6B-421B-9274-5DD04249F4BCQ36310174-683F471A-F508-4944-8F44-07AFF6302BE6Q36342450-759E8638-EB15-4C4E-B60F-A4DABD77E088Q36443010-8C1DD39D-DCB8-45BA-8B60-AC2EE26603AFQ36908704-D064157F-10DF-4B91-82D7-DB108825A738Q36980707-E7E7021F-8A11-4FE0-8478-7980AF8D3988Q36984116-9C682F57-8DA1-42C6-98CE-55248D6A2FF0Q37071057-82AFC84A-5F50-46F6-A54A-26D4E50307CFQ37213531-302F13B0-2AD4-44C1-B196-CF3A28E293EDQ37218356-C9BE1318-6B6D-46C4-AC35-38246156AC8EQ37383972-84484017-7DAF-4EA1-8DE1-BA941C74FDC5Q37421126-5522035D-D13B-4C1D-A61D-473EE4507A64Q37469694-2E1872D5-A313-420F-BABA-251B66554DD1Q37558440-B924C0CC-962C-4A7B-A612-7E37ED091BE7
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Epilepsy and the natural history of Rett syndrome.
@ast
Epilepsy and the natural history of Rett syndrome.
@en
type
label
Epilepsy and the natural history of Rett syndrome.
@ast
Epilepsy and the natural history of Rett syndrome.
@en
prefLabel
Epilepsy and the natural history of Rett syndrome.
@ast
Epilepsy and the natural history of Rett syndrome.
@en
P2093
P2860
P1433
P1476
Epilepsy and the natural history of Rett syndrome
@en
P2093
J O Barrish
S P Geerts
P2860
P304
P356
10.1212/WNL.0B013E3181D6B852
P407
P577
2010-03-01T00:00:00Z